Advertisement

Abetalipoproteinemia

  • Jacob Valk
  • Marjo S. van der Knaap

Abstract

Abetalipoproteinemia was first described by Bassen and Kornzweig, and it is also referred to a Bassen-Kornzweig syndrome. The disease has an autosomal recessive mode of inheritance. The clinical syndrome is dominated by symptoms of intestinal malabsorption and growth retardation. Neurological symptoms usually become manifest after 5 years of age, but sometimes earlier. The most prominent feature is progressive ataxia. In addition, progressive generalized weakness occurs, with ptosis, ophthalmoplegia, facial weakness, and weakness of the tongue and extremities. Pigmentary retinal degeneration, also involving the macula, leads to progressive visual failure. Neurological examination reveals nystagmus, absence of tendon reflexes, and often extensor plantar reflexes and muscular wasting, which may be severe. Sensory examination reveals a severe loss of vibration and position sense, whereas the superficial sensation is relatively preserved. The ataxia is the result of disturbed sensation in combination with cerebellar dysfunction. Kyphoscoliosis and pes cavus are often present. Cardiomegaly, congestive heart failure, and arrhythmia are sometimes noted. The neurological picture may remain stationary for many years or be insidiously progressive, so that the disease runs a protracted course.

Keywords

Retinitis Pigmentosa Retinal Degene Cerebellar Dysfunction Facial Weakness Intestinal Malabsorption 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Azizi E, Zaidman JL, Eshchar J, Szeinberg A (1978) Abetalipoproteinema treated with parenteral and oral vitamins A and E, and with medium chain triglycerides. Acta Pediatr Scand 67: 797–801CrossRefGoogle Scholar
  2. Bruyn GW (1977) Bassen-Kornzweig disease. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology, vol 29. Amsterdam: North Holland Publishing Company: 401–427Google Scholar
  3. MacGilchrist AJ, Mills PR, Noble M, Foulds WS, et al. (1988) Abetalipoproteinaemia in adults: role of vitamin therapy. J Inher Metab Dis 11: 184–190PubMedCrossRefGoogle Scholar
  4. Muller DPR, Lloyd JK, Bird AC (1977) Long-term management of abetalipoproteinaemia. Arch Dis Child 52: 209–214PubMedCrossRefGoogle Scholar
  5. Reddy JK, Warren JR, Reddy MK, Lalwani ND (1982) Hepatic and renal effects of peroxisome proliferators: biological implications. Ann NY Acad Sci 386: 81–110PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • Jacob Valk
    • 1
  • Marjo S. van der Knaap
    • 2
  1. 1.Department of Diagnostic Radiology and NeuroradiologyFree University HospitalAmsterdamThe Netherlands
  2. 2.Department of Child NeurologyAcademic HospitalUtrechtThe Netherlands

Personalised recommendations